- Experience with TPO agonist treatment in children in view of new guidelines2021 | Publication without faculty affiliation
- Dopamine receptor partial agonists: the same or different?2021 | Faculty of Medicine in Hradec Králové
- Individualization of therapy for type 2 diabetes: GLP-1 agonists2015 | First Faculty of Medicine
- Valvular heart disease in relation to the treatment of hyperprolactinemia with dopamine agonists2017 | Faculty of Medicine in Hradec Králové
- Nonpeptide agonists of GLP 12013 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Racionální a účinná kombinace agonisty GLP-1 receptoru a bazálního inzulinu2021 | First Faculty of Medicine
- Nearby future of dual agonists of PPAR2013 | Second Faculty of Medicine
- Use of dopamine agonists in Parkinson's disease2014 | Publication without faculty affiliation
- The effect of GLP‑1 receptor agonists on improving glucose control and decreasing body weight: results of direct comparative trials and network meta‑analysis2022 | First Faculty of Medicine
- Cardioascular effect of incretin-based therapies: comparison od DPP-4 inhibitors and GLP-1 agonists2014 | First Faculty of Medicine
- Benefits of GLP-1 receptor agonists therapy for patients with cardiovascular disease2022 | First Faculty of Medicine
- Importance of alfa-2 adrenergyc agonists in glaucoma treatmentPublication without faculty affiliation
- Effect of PPAR gamma agonist, antagonist and beta3 agonist/antagonist on adiponectin, resistin, NO, TNF-alfa and lipolysis in rat adipocytesPublication without faculty affiliation
- John T. Shawcross, The Uncertain World of Samson Agonistes2006 | Faculty of Arts
- Dopamine agonists treatment in Parkinson's disease: experience with Pergolide2000 | First Faculty of Medicine
- Albiglutide - a GLP-1 agonist with a prolonged action2017 | First Faculty of Medicine, Third Faculty of Medicine
- Dopamine agonist-induced generalized edema in Parkinson's disease2009 | First Faculty of Medicine
- Treatment of type 2 diabetes mellitus by GLP-1 agonists2011 | First Faculty of Medicine
- Growth and Final Height in Girls with Central Precocious Puberty after Long-term Treatment with Depot Gonadoliberin Analogue2005 | Second Faculty of Medicine
- Initiation of therapy and utilization of dopamine agonists in early period of Parkinson's disease2004 | First Faculty of Medicine
- Lixisenatide - a novel prandial GLP-1 receptor agonist2013 | Second Faculty of Medicine
- Kardiovaskulární a renální účinky efpeglenatidu, agonisty receptoru pro GLP 1, jsou aditivní k účinkům inhibitorů SGLT22021 | First Faculty of Medicine
- Effect of pharmacological protection of gonads in patients with malignancies by gonadoliberine agonists and antagonistsPublication without faculty affiliation
- PPAR agonist and blood pressure2006 | First Faculty of Medicine
- Dual agonists of PPAR receptors2006 | First Faculty of Medicine
- Comparison of human chorionic gonadotropin (Pregnyl 10 000 IU i.m.) versus GnRH agonist (triptorelin 0,2 mg s.c.) for final oocytes maturation in the same egg donors - clinical and embryological characteristics2011 | Third Faculty of Medicine
- Beta-3 agonist-induced lipolysis and nitric oxide production: relationship to PPARgamma agonist/antagonist and AMP kinase modulation2011 | First Faculty of Medicine
- Retrospective investigation of the role of D2 receptor agonists on bleeding into macroprolactinomas in MRI and on their clinical manifestations2005 | First Faculty of Medicine
- Agonization of GLP-1 in cardiology2020 | Faculty of Medicine in Pilsen